Back to search

Belgium· BE-AMP-SAM174115-00

Harmonet 0.075 mg - 0.02 mg

A gestodene and ethinylestradiol product containing ethinylestradiol, registered in Belgium by Pfizer. The same ATC class is registered in 9 of our 19 countries.

ATC G03AA10

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedHarmonet 0.075 mg - 0.02 mgATCG03AA10REGISTER NO.BE-AMP-SAM174115-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Gestodene and ethinylestradiol is registered in 9 of 19 countries.

Countries holding a registration under ATC G03AA10 (gestodene and ethinylestradiol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Gestodene and ethinylestradiol · ATC G03AA10

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ethinylestradiol
Manufacturer
Pfizer
Country
Belgium (BE)
ATC code
G03AA10
ATC class
Gestodene and ethinylestradiol
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7704729
  • be_apb
    1224401

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for gestodene and ethinylestradiol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gestodene and ethinylestradiol · interactions on record

31 records

31 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Gestodene and ethinylestradiol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gestodene and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Ethinyloestradiol Effik
  • Netherlands · Acelyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f30b385f-f9dc-4eaf-bdab-de9e7cb93010
GET /v1/drugs/f30b385f-f9dc-4eaf-bdab-de9e7cb93010?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Harmonet 0.075 mg - 0.02 mg",
  "name_fr": "Harmonet 0.075 mg - 0.02 mg",
  "name_nl": "Harmonet 0.075 mg - 0.02 mg",
  "amp_code": "SAM174115-00",
  "strengths": [
    "0.0200",
    "0.0750",
    "37.5050",
    "19.6600"
  ],
  "pack_count": 2,
  "substances": [
    "Ethinylestradiol",
    "Gestodene",
    "Lactose Monohydrate",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Gestodene and Ethinylestradiol",
  "authorisation_numbers": [
    "BE174115"
  ]
}

See everything about gestodene and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.